Company profile
MedAvail Holdings, Inc.
OTC: MDVLQ · Healthcare · Medical - Pharmaceuticals
#453 of 1,418 Healthcare companies by revenuetop-quartile growth
EA Score
——FH —DQ 51GM —SS 34
v0.1 · 25/100 weight · pillars only
↑ 3-yr revenue growth, revenue growth (YoY) · ↓ market scale, growth stability
Methodology →Revenue TTM
$23.8M
Rev growth YoY (TTM)
-28.6%
Net income (FY)
-$47.6M
Employees
279
as of 2026-08-31
Market cap
$161
as of 2026-08-31
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$43.1M$43.1M2022
Net income-$47.6M-$47.6M2022
Operating income-$46.4M-$46.4M2022
Total assets$33.1M$33.1M2022
Liabilities$12.3M$12.3M2022
Equity$20.8M$20.8M2022
Revenue trend
FY2015 – FY2022 · USD
FY15
FY16
FY18
FY18
FY19
FY20
FY21
FY22
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is MedAvail Holdings, Inc.’s revenue?
MedAvail Holdings, Inc. booked $43.1M in FY2022 revenue, growing 95% year over year — faster than most Healthcare companies we track, at a -110.5% net margin.
Peers · Healthcare
SANUWAVE Health Inc.74BHOOKIPA Pharma Inc.——Xilio Therapeutics, Inc.38DWave Life Sciences Ltd.63CRubicon Organics Inc.63CSS Innovations International, Inc.53DNeighbors
Maricopa →Key facts
CEOEmilia Keric
SectorHealthcare
IndustryMedical - Pharmaceuticals
HeadquartersPhoenix, AZ
ExchangeOTC: MDVLQ
Employees279
IPO date2020-11-18
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.